Biotechnology
RSS Feed

American Cryostem Corporation 2017 Year End Update
1/16/2018 -- 6:00 AM -- American CryoStem Corporation

American CryoStem Statement on the Receipt of a Warning Letter from FDA
1/8/2018 -- 6:00 AM -- American CryoStem Corporation

Molecular Partners Reports Promising Initial Safety and Efficacy Data From its Ongoing phase 2 Study of MP0250 in Multiple Myeloma
1/8/2018 -- 1:00 AM -- Molecular Partners AG

Molecular Partners to Present at The 36th Annual J.P. Morgan Healthcare Conference
1/4/2018 -- 1:00 AM -- Molecular Partners AG

LBTD Explains COIN Rig Solutions, Obtains First Servers for Intelligent Mining and Global Strategy of Monetization
12/27/2017 -- 2:00 PM -- Lotus BioTechnology Development Corp.

LBTD Agrees to Purchase COIN Solutions to Enter Cryptocurrency with Cutting Edge Algorithm and Artificial Intelligence Software
12/22/2017 -- 3:30 PM -- Lotus BioTechnology Development Corp.

Calmare Therapeutics Cautions Shareholders
12/20/2017 -- 10:37 AM -- Calmare Therapeutics Incorporated

Pressure BioSciences Enters Biopharmaceutical Quality Control Market with Significant Software Upgrade for Its Flagship Barocycler 2320EXTREME
12/20/2017 -- 9:35 AM -- Pressure BioSciences, Inc.

AYOXXA To Present @ Biotech Showcase 2018
12/20/2017 -- 7:45 AM -- AYOXXA Biosystems GmbH

Pressure BioSciences, Inc. to Host Business Update on Wednesday, December 20th at 4:30 pm EST
12/18/2017 -- 9:29 AM -- Pressure BioSciences, Inc.

Genoptix to Acquire Rosetta Genomics for $10 Million in Cash
12/15/2017 -- 9:00 AM -- Rosetta Genomics Ltd.

MorphoSys to Present at Upcoming Investor Conferences
12/14/2017 -- 10:20 AM -- MorphoSys AG

Pressure BioSciences Announces Acquisition of All Assets of BaroFold, Inc.
12/13/2017 -- 9:15 AM -- Pressure BioSciences, Inc.

MorphoSys AG: Corporate Calendar 2018
12/11/2017 -- 10:20 AM -- MorphoSys AG

XCELL BIOLOGIX(TM) Signs Exclusive Worldwide Licensing Agreement with the Wake Forest Institute for Regenerative Medicine for Development and Commercialization of Novel Tissue Regeneration Technology for Healing Chronic Wounds and Severe Burns
12/11/2017 -- 9:00 AM -- XCELL BIOLOGIX

MorphoSys Presents Clinical Data on MOR208 plus Lenalidomide in Aggressive Lymphoma (R/R DLBCL) at ASH 2017 Conference
12/11/2017 -- 8:30 AM -- MorphoSys AG

Michael Aronstein to Head AngioGenex, Inc. Board of Directors
12/5/2017 -- 3:30 PM -- AngioGenex, Inc.

MorphoSys to Host Investor & Analyst Call On December 12, 2017 About Data On MOR208 Presented at the 2017 ASH Annual Meeting
12/5/2017 -- 9:30 AM -- MorphoSys AG

AYOXXA Launches LUNARIS(TM) Human 11-Plex Ophthalmology Kit
12/5/2017 -- 3:30 AM -- AYOXXA Biosystems GmbH

MorphoSys Announces That Its Licensee Janssen Has Received Approval for Tremfya(R) (Guselkumab) for the Treatment of Moderate-to-Severe Plaque Psoriasis in Canada
12/5/2017 -- 2:00 AM -- MorphoSys AG